Discovery Research Articles

  1. Modelling TPDs Utilizing Computational And Medicinal Chemistry Approaches 5/16/2025

    Through a carefully executed strategy, see how we identified novel degrader molecules with the right physicochemical properties to achieve robust degradation of the target Protein of Interest (POI).

  2. A Pre-Clinical Study For Diet-Induced Obesity 3/28/2025

    Here, we look at the importance of using high-fat diet-induced obesity models to evaluate and compare the efficacy of anti-obesity and anti-diabetic treatments like rimonabant and liraglutide.

  3. Aragen's Preclinical Oncology Capabilities 3/27/2025

    We provide specialized in vivo pharmacology services, offering customized solutions to support the development of immune-oncology therapies from discovery to commercialization.

  4. Propelling Glioblastoma Research: Orthotopic Model Solutions 3/27/2025

    Utilize our luciferase-based orthotopic GBM model to accelerate your research on glioblastoma therapies, offering precise tumor monitoring and non-invasive assessment of treatment efficacy.

  5. Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology 3/12/2025

    Scale up your manufacturing of adherent cell cultures used for viral vector-based treatments with the novel technologies needed to facilitate safe, rapid production.

  6. How Platform Technologies Power Up Processes From Lab To cGMP 10/30/2024

    This expert Q&A examines ways to push the envelope of expression system technology and process characterization while maximizing user transparency.

  7. Designing, Selecting, And Developing Bioconjugates For Clinical Success 10/24/2024

    Accelerate the development of complex bioconjugates to unlock new possibilities for targeted therapies and advance the next generation of precision medicine.

  8. Bioconjugates – An Increasing Diversity, A Blossoming Of Therapeutic Applications 10/24/2024

    Harness the power of bioconjugation to revolutionize targeted therapies, enhance drug efficacy, and reduce side effects, paving the way for more precise and effective treatments across a range of diseases.

  9. Transient Expression Platform: discoCHO 10/4/2024

    Learn how this transient platform accelerates biologics production, seamlessly transitioning from discovery to stable CHO-K1, ensuring scalability, and reducing risks in manufacturing therapeutic biologics.

  10. Streamlining The Importing & Exporting Of Biological Samples 9/1/2024

    Create a seamless and predictable import and export process by working with experienced bioanalytical laboratory partners, understanding what paperwork samples require, and proactive planning.